Increasing Demand For Minimally Invasive Angioplasty Treatments Driving Global Interventional Cardiology And Peripheral Vascular Devices Market

Factors such as the aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are expected to drive the growth of this market.The interventional cardiology market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1%.

Get PDF Brochure Here: http://bit.ly/2uDGzna

Key players :

The major players in the interventional cardiology market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).

About Report :

On the basis of type, the angioplasty stent market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the angiography catheters segment is expected to account for the largest share of the market.On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is expected to account for the largest share primarily due to the rising incidence of smoking and hypertension.

Value Addition for the Buyer:

This report aims to provide insights into the global interventional cardiology & peripheral vascular devices market. It provides valuable information on interventional cardiology & peripheral vascular devices product segment and end user. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.

To Know More About It: http://bit.ly/2uE8eog